Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer

Clinical trial NCT00392769 · COMPLETED

Trial details

NCT number: NCT00392769
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Cancer

Start date: 2006-10-01
Primary completion: 2010-12-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.